6533b857fe1ef96bd12b3c60
RESEARCH PRODUCT
Meta-analysis of Randomized Controlled Trials and Individual Patient Data Comparing Minimally Invasive With Open Oesophagectomy for Cancer
C A GutschowS FazeliThomas SchmidtT S Dabakuyo-yonliB. P. Müller-stichR. Van HillegersbergGuillaume PiessenHenrik NienhüserP.c. Van Der SluisEva KalkumM PairederPeter P. GrimmingerMarkus K. DienerArnulf H. HölscherJonas D SenftFelix NickelSebastian F. SchoppmannPascal ProbstRene WarschkowPatrick HegerMiguel A. CuestaD. L. Van Der PeetAdrian T. Billetersubject
medicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatment610 Medicine & healthLower risklaw.inventionRandomized controlled triallawOpen ResectionMedicineHumansMinimally Invasive Surgical ProceduresRandomized Controlled Trials as Topic10217 Clinic for Visceral and Transplantation Surgerybusiness.industryCancerOdds ratioPerioperativeLength of Staymedicine.diseaseSurgery2746 SurgeryEsophagectomyTreatment OutcomeEsophagectomyMeta-analysisSurgerybusinessdescription
Minimally invasive oesophagectomy (MIO) for oesophageal cancer may reduce surgical complications compared with open oesophagectomy. MIO is, however, technically challenging and may impair optimal oncological resection. The aim of the present study was to assess if MIO for cancer is beneficial.A systematic literature search in MEDLINE, Web of Science and CENTRAL was performed and randomized controlled trials (RCTs) comparing MIO with open oesophagectomy were included in a meta-analysis. Survival was analysed using individual patient data. Random-effects model was used for pooled estimates of perioperative effects.Among 3219 articles, six RCTs were identified including 822 patients. Three-year overall survival (56 (95 per cent c.i. 49 to 62) per cent for MIO versus 52 (95 per cent c.i. 44 to 60) per cent for open; P = 0.54) and disease-free survival (54 (95 per cent c.i. 47 to 61) per cent versus 50 (95 per cent c.i. 42 to 58) per cent; P = 0.38) were comparable. Overall complication rate was lower for MIO (odds ratio 0.33 (95 per cent c.i. 0.20 to 0.53); P 0.010) mainly due to fewer pulmonary complications (OR 0.44 (95 per cent c.i. 0.27 to 0.72); P 0.010), including pneumonia (OR 0.41 (95 per cent c.i. 0.22 to 0.77); P 0.010).MIO for cancer is associated with a lower risk of postoperative complications compared with open resection. Overall and disease-free survival are comparable for the two techniques.Oesophagectomy for cancer is associated with a high risk of complications. A minimally invasive approach might be less traumatic, leading to fewer complications and may also improve oncological outcome. A meta-analysis of randomized controlled trials comparing minimally invasive to open oesophagectomy was performed. The analysis showed that the minimally invasive approach led to fewer postoperative complications, in particular, fewer pulmonary complications. Survival after surgery was comparable for the two techniques.Oesophagectomy for cancer is associated with a high risk of complications. A minimally invasive approach might be less traumatic, leading to fewer complications and may also improve oncological outcome. A meta-analysis of randomized controlled trials comparing minimally invasive to open oesophagectomy was performed. The analysis showed that the minimally invasive approach led to fewer postoperative complications, in particular, fewer pulmonary complications. Survival after surgery was comparable for the two techniques.
year | journal | country | edition | language |
---|---|---|---|---|
2021-09-27 |